Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses

Journal of Experimental Medicine

Volumn 210, Issue 8, 2013, Pages 1509-1528

  Das, Suvendu ^a   Sarrou, Eliana ^a   Podgrabinska, Simona ^a   Cassella, Melanie ^a   Mungamuri, Sathish Kumar ^a   Feirt, Nikki ^b   Gordon, Ronald ^a   Nagi, Chandandeep S ^a   Wang, Yarong ^c   Entenberg, David ^c   Condeelis, John ^c   Skobe, Mihaela ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CCL1 CHEMOKINE; CHEMOKINE RECEPTOR CCR8; INTERLEUKIN 1BETA; MESSENGER RNA; SHORT HAIRPIN RNA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; BREAST CANCER; CELL CYCLE ARREST; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPH NODE; LYMPH NODE METASTASIS; MELANOCYTE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CCL1; CHEMOTACTIC FACTORS; CHEMOTAXIS; CYTOKINES; ENDOTHELIAL CELLS; ENDOTHELIUM, LYMPHATIC; HUMANS; INFLAMMATION MEDIATORS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MELANOMA; MICE; MICROSCOPY, FLUORESCENCE, MULTIPHOTON; NEOPLASMS; RECEPTORS, CCR8; TIME-LAPSE IMAGING;

EID: 84883192541     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20111627     Document Type: Article

References (92)

1. Achen, M.G., B.K. McColl, and S.A. Stacker. 2005. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell. 7:121-127. http://dx.doi .org/10.1016/j.ccr.2005.01.017
2. Alitalo, K., T. Tammela, and T.V. Petrova. 2005. Lymphangiogenesis in development and human disease. Nature. 438:946-953. http://dx.doi .org/10.1038/nature04480
3. Alon, R., and K. Ley. 2008. Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells. Curr. Opin. Cell Biol. 20:525-532. http://dx.doi.org/10.1016/j.ceb.2008.04.003
4. Alon, R., and Z. Shulman. 2011. Chemokine triggered integrin activation and actin remodeling events guiding lymphocyte migration across vascular barriers. Exp. Cell Res. 317:632-641. http://dx.doi.org/10 .1016/j.yexcr.2010.12.007
5. Balch, C.M., A.C. Buzaid, S.J. Soong, M.B. Atkins, N. Cascinelli, D.G. Coit, I.D. Fleming, J.E. Gershenwald, A. Houghton Jr., J.M. Kirkwood, et al. 2001. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J. Clin. Oncol. 19:3635-3648.
6. Ben-Baruch, A. 2008. Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin. Exp. Metastasis. 25:345-356. http:// dx.doi.org/10.1007/s10585-007-9097-3
7. Braun, A., T. Worbs, G.L. Moschovakis, S. Halle, K. Hoffmann, J. Bölter, A. Münk, and R. Förster. 2011. Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration. Nat. Immunol. 12:879-887. http://dx.doi.org/10.1038/ni.2085
8. Burger, J.A., M. Burger, and T.J. Kipps. 1999. Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood. 94:3658-3667.
9. Cabioglu, N., M.S. Yazici, B. Arun, K.R. Broglio, G.N. Hortobagyi, J.E. Price, and A. Sahin. 2005. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin. Cancer Res. 11:5686-5693. http://dx.doi.org/10.1158/1078-0432. CCR-05-0014
10. Carr, I. 1983. Lymphatic metastasis. Cancer Metastasis Rev. 2:307-317. http://dx.doi.org/10.1007/BF00048483
11. Carr, I., M. Levy, K. Orr, and J. Bruni. 1985. Lymph node metastasis and cell movement: ultrastructural studies on the rat 13762 mammary carcinoma and Walker carcinoma. Clin. Exp. Metastasis. 3:125-139. http:// dx.doi.org/10.1007/BF01758961
12. Chensue, S.W., N.W. Lukacs, T.Y. Yang, X. Shang, K.A. Frait, S.L. Kunkel, T. Kung, M.T. Wiekowski, J.A. Hedrick, D.N. Cook, et al. 2001. Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice. J. Exp. Med. 193:573-584. http://dx.doi.org/10.1084/jem.193.5.573
13. Cohen, J.N., C.J. Guidi, E.F. Tewalt, H. Qiao, S.J. Rouhani, A. Ruddell, A.G. Farr, K.S. Tung, and V.H. Engelhard. 2010. Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J. Exp. Med. 207:681-688. http:// dx.doi.org/10.1084/jem.20092465
14. Condeelis, J., and J.E. Segall. 2003. Intravital imaging of cell movement in tumours. Nat. Rev. Cancer. 3:921-930. http://dx.doi.org/10.1038/nrc1231
15. D'Ambrosio, D., A. Iellem, R. Bonecchi, D. Mazzeo, S. Sozzani, A. Mantovani, and F. Sinigaglia. 1998. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J. Immunol. 161:5111-5115.
16. Dadiani, M., V. Kalchenko, A. Yosepovich, R. Margalit, Y. Hassid, H. Degani, and D. Seger. 2006. Real-time imaging of lymphogenic metastasis in orthotopic human breast cancer. Cancer Res. 66:8037-8041. http://dx.doi.org/10.1158/0008-5472.CAN-06-0728
17. Das, S., and M. Skobe. 2008. Lymphatic vessel activation in cancer. Ann. N. Y. Acad. Sci. 1131:235-241. http://dx.doi.org/10.1196/annals.1413.021
18. Das, S., D.S. Ladell, S. Podgrabinska, V. Ponomarev, C. Nagi, J.T. Fallon, and M. Skobe. 2010. Vascular endothelial growth factor-C induces lymphangitic carcinomatosis, an extremely aggressive form of lung metastases. Cancer Res. 70:1814-1824. http://dx.doi.org/10.1158/0008- 5472.CAN-09-3675
19. Debes, G.F., C.N. Arnold, A.J. Young, S. Krautwald, M. Lipp, J.B. Hay, and E.C. Butcher. 2005. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat. Immunol. 6:889-894. http://dx.doi.org/10.1038/ni1238
20. Dewar, D.J., B. Newell, M.A. Green, A.P. Topping, B.W. Powell, and M.G. Cook. 2004. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J. Clin. Oncol. 22:3345-3349. http://dx.doi.org/10.1200/JCO.2004.12.177
21. Düllmann, J., E.J. Van Damme, W.J. Peumans, M. Ziesenitz, and U. Schumacher. 2002. Lectin histochemistry of the rat lymph node: visualisation of stroma, blood vessels, sinuses, and macrophages. A contribution to the concept of an immune accessory role of sinus-lining endothelia. Acta Histochem. 104:77-83. http://dx.doi.org/10.1078/0065-1281-00616
22. Ebert, L.M., S. Meuter, and B. Moser. 2006. Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance. J. Immunol. 176:4331-4336.
23. Entenberg, D., J. Wyckoff, B. Gligorijevic, E.T. Roussos, V.V. Verkhusha, J.W. Pollard, and J. Condeelis. 2011. Setup and use of a two-laser multiphoton microscope for multichannel intravital fluorescence imaging. Nat. Protoc. 6:1500-1520. http://dx.doi.org/10.1038/ nprot.2011.376
24. Förster, R., A. Braun, and T. Worbs. 2012. Lymph node homing of T cells and dendritic cells via afferent lymphatics. Trends Immunol. 33:271-280. http://dx.doi.org/10.1016/j.it.2012.02.007
25. Fossum, S. 1980. The architecture of rat lymph nodes. IV. Distribution of ferritin and colloidal carbon in the draining lymph nodes after foot-pad injection. Scand. J. Immunol. 12:433-441. http://dx.doi.org/10.1111/ j.1365-3083.1980.tb00087.x
26. Gombert, M., M.C. Dieu-Nosjean, F. Winterberg, E. Bünemann, R.C. Kubitza, L. Da Cunha, A. Haahtela, S. Lehtimäki, A. Müller, J. Rieker, et al. 2005. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J. Immunol. 174:5082-5091.
27. Goya, I., J. Gutiérrez, R. Varona, L. Kremer, A. Zaballos, and G. Márquez. 1998. Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3. J. Immunol. 160:1975-1981.
28. Greene, F.L., D.L. Page, I.D. Fleming, A. Fritz, D.M. Balch, D.G. Haller, M. Morrow., eds. 2002. AJCC Cancer Staging Manual, 6th Ed. Springer- Verlag, New York. 435 pp.
29. Gretz, J.E., C.C. Norbury, A.O. Anderson, A.E. Proudfoot, and S. Shaw. 2000. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J. Exp. Med. 192:1425-1440. http://dx.doi.org/10 .1084/jem.192.10.1425
30. Gunn, M.D., K. Tangemann, C. Tam, J.G. Cyster, S.D. Rosen, and L.T. Williams. 1998. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA. 95:258-263. http://dx.doi.org/10.1073/pnas.95.1.258
31. Haque, N.S., J.T. Fallon, J.J. Pan, M.B. Taubman, and P.C. Harpel. 2004. Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion. Blood. 103:1296- 1304. http://dx.doi.org/10.1182/blood-2002-05-1480
32. Hayashi, K., P. Jiang, K. Yamauchi, N. Yamamoto, H. Tsuchiya, K. Tomita, A.R. Moossa, M. Bouvet, and R.M. Hoffman. 2007. Realtime imaging of tumor-cell shedding and trafficking in lymphatic channels. Cancer Res. 67:8223-8228. http://dx.doi.org/10.1158/0008-5472. CAN-07-1237
33. Houshmand, P., and A. Zlotnik. 2003. Therapeutic applications in the chemokine superfamily. Curr. Opin. Chem. Biol. 7:457-460. http://dx.doi .org/10.1016/S1367-5931(03)00086-3
34. Ishigami, S., S. Natsugoe, A. Nakajo, K. Tokuda, Y. Uenosono, T. Arigami, M. Matsumoto, H. Okumura, S. Hokita, and T. Aikou. 2007. Prognostic value of CCR7 expression in gastric cancer. Hepatogastroenterology. 54:1025-1028.
35. Islam, S.A., D.S. Chang, R.A. Colvin, M.H. Byrne, M.L. McCully, B. Moser, S.A. Lira, I.F. Charo, and A.D. Luster. 2011. Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells. Nat. Immunol. 12:167-177. http://dx.doi.org/10.1038/ni.1984
36. Jamieson, T., D.N. Cook, R.J. Nibbs, A. Rot, C. Nixon, P. McLean, A. Alcami, S.A. Lira, M. Wiekowski, and G.J. Graham. 2005. The chemokine receptor D6 limits the inflammatory response in vivo. Nat. Immunol. 6:403-411. http://dx.doi.org/10.1038/ni1182
37. Jia, L., Z. Xie, J. Zheng, L. Liu, Y. He, F. Liu, and Y. He. 2012. Morphological studies of lymphatic labyrinths in the rat mesenteric lymph node. Anat. Rec. (Hoboken). 295:1291-1301. http://dx.doi.org/10.1002/ar.22509
38. Junt, T., E.A. Moseman, M. Iannacone, S. Massberg, P.A. Lang, M. Boes, K. Fink, S.E. Henrickson, D.M. Shayakhmetov, N.C. Di Paolo, et al. 2007. Subcapsular sinus macrophages in lymph nodes clear lymphborne viruses and present them to antiviral B cells. Nature. 450:110-114. http://dx.doi.org/10.1038/nature06287
39. Kerjaschki, D., H.M. Regele, I. Moosberger, K. Nagy-Bojarski, B. Watschinger, A. Soleiman, P. Birner, S. Krieger, A. Hovorka, G. Silberhumer, et al. 2004. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am. Soc. Nephrol. 15:603-612. http://dx.doi.org/10.1097/01 .ASN.0000113316.52371.2E
40. Li, J.L., C.C. Goh, J.L. Keeble, J.S. Qin, B. Roediger, R. Jain, Y. Wang, W.K. Chew, W. Weninger, and L.G. Ng. 2012. Intravital multiphoton imaging of immune responses in the mouse ear skin. Nat. Protoc. 7:221-234. http://dx.doi.org/10.1038/nprot.2011.438
41. Lindquist, R.L., G. Shakhar, D. Dudziak, H. Wardemann, T. Eisenreich, M.L. Dustin, and M.C. Nussenzweig. 2004. Visualizing dendritic cell networks in vivo. Nat. Immunol. 5:1243-1250. http://dx.doi.org/ 10.1038/ni1139
42. Louahed, J., S. Struyf, J.B. Demoulin, M. Parmentier, J. Van Snick, J. Van Damme, and J.C. Renauld. 2003. CCR8-dependent activation of the RAS/MAPK pathway mediates anti-apoptotic activity of I-309/ CCL1 and vMIP-I. Eur. J. Immunol. 33:494-501. http://dx.doi.org/ 10.1002/immu.200310025
43. Luo, Y., J. Laning, S. Devi, J. Mak, T.J. Schall, and M.E. Dorf. 1994. Biologic activities of the murine beta-chemokine TCA3. J. Immunol. 153:4616-4624.
44. Lüttichau, H.R., J. Stine, T.P. Boesen, A.H. Johnsen, D. Chantry, J. Gerstoft, and T.W. Schwartz. 2000. A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum. J. Exp. Med. 191:171-180. http://dx.doi.org/10.1084/jem.191.1.171
45. Lüttichau, H.R., J. Gerstoft, and T.W. Schwartz. 2001. MC148 encoded by human molluscum contagiosum poxvirus is an antagonist for human but not murine CCR8. J. Leukoc. Biol. 70:277-282.
46. Martens, J.H., J. Kzhyshkowska, M. Falkowski-Hansen, K. Schledzewski, A. Gratchev, U. Mansmann, C. Schmuttermaier, E. Dippel, W. Koenen, F. Riedel, et al. 2006. Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis. J. Pathol. 208:574-589. http://dx.doi.org/10.1002/path.1921
47. Mashino, K., N. Sadanaga, H. Yamaguchi, F. Tanaka, M. Ohta, K. Shibuta, H. Inoue, and M. Mori. 2002. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res. 62:2937-2941.
48. Miller, M.D., and M.S. Krangel. 1992. The human cytokine I-309 is a monocyte chemoattractant. Proc. Natl. Acad. Sci. USA. 89:2950-2954. http://dx.doi.org/10.1073/pnas.89.7.2950
49. Miller, M.D., S. Hata, R. De Waal Malefyt, and M.S. Krangel. 1989. A novel polypeptide secreted by activated human T lymphocytes. J. Immunol. 143:2907-2916.
50. Morton, D.L., J.F. Thompson, A.J. Cochran, N. Mozzillo, R. Elashoff, R. Essner, O.E. Nieweg, D.F. Roses, H.J. Hoekstra, C.P. Karakousis, et al; MSLT Group. 2006. Sentinel-node biopsy or nodal observation in melanoma. N. Engl. J. Med. 355:1307-1317. http://dx.doi.org/10 .1056/NEJMoa060992
51. Müller, A., B. Homey, H. Soto, N. Ge, D. Catron, M.E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S.N. Wagner, et al. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:50-56. http://dx.doi.org/10.1038/35065016
52. Nathanson, S.D. 2003. Insights into the mechanisms of lymph node metastasis. Cancer. 98:413-423. http://dx.doi.org/10.1002/cncr.11464
53. Ohtani, O., and Y. Ohtani. 2008. Structure and function of rat lymph nodes. Arch. Histol. Cytol. 71:69-76. http://dx.doi.org/10.1679/aohc.71.69
54. Ohtani, O., Y. Ohtani, C.J. Carati, and B.J. Gannon. 2003. Fluid and cellular pathways of rat lymph nodes in relation to lymphatic labyrinths and Aquaporin-1 expression. Arch. Histol. Cytol. 66:261-272. http://dx.doi .org/10.1679/aohc.66.261
55. Pape, K.A., D.M. Catron, A.A. Itano, and M.K. Jenkins. 2007. The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity. 26:491-502. http://dx.doi.org/10.1016/j.immuni.2007.02.011
56. Pawlik, T.M., M.I. Ross, J.F. Thompson, A.M. Eggermont, and J.E. Gershenwald. 2005. The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes. J. Clin. Oncol. 23:4588-4590. http://dx.doi.org/10.1200/JCO.2005.12.245
57. Pepper, M.S., and M. Skobe. 2003. Lymphatic endothelium: morphological, molecular and functional properties. J. Cell Biol. 163:209-213. http:// dx.doi.org/10.1083/jcb.200308082
58. Pfeiffer, F., V. Kumar, S. Butz, D. Vestweber, B.A. Imhof, J.V. Stein, and B. Engelhardt. 2008. Distinct molecular composition of blood and lymphatic vascular endothelial cell junctions establishes specific functional barriers within the peripheral lymph node. Eur. J. Immunol. 38:2142- 2155. http://dx.doi.org/10.1002/eji.200838140
59. Phan, T.G., I. Grigorova, T. Okada, and J.G. Cyster. 2007. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat. Immunol. 8:992-1000. http://dx.doi.org/10 .1038/ni1494
60. Podgrabinska, S., P. Braun, P. Velasco, B. Kloos, M.S. Pepper, and M. Skobe. 2002. Molecular characterization of lymphatic endothelial cells. Proc. Natl. Acad. Sci. USA. 99:16069-16074. http://dx.doi.org/10.1073/ pnas.242401399
61. Podgrabinska, S., O. Kamalu, L. Mayer, M. Shimaoka, H. Snoeck, G.J. Randolph, and M. Skobe. 2009. Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1- dependent mechanism. J. Immunol. 183:1767-1779. http://dx.doi.org/10 .4049/jimmunol.0802167
62. Qu, C., E.W. Edwards, F. Tacke, V. Angeli, J. Llodrá, G. Sanchez-Schmitz, A. Garin, N.S. Haque, W. Peters, N. van Rooijen, et al. 2004. Role of CCR8 and other chemokine pathways in the migration of monocytederived dendritic cells to lymph nodes. J. Exp. Med. 200:1231-1241. http://dx.doi.org/10.1084/jem.20032152
63. Roberts, N., B. Kloos, M. Cassella, S. Podgrabinska, K. Persaud, Y. Wu, B. Pytowski, and M. Skobe. 2006. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res. 66:2650- 2657. http://dx.doi.org/10.1158/0008-5472.CAN-05-1843
64. Roos, R.S., M. Loetscher, D.F. Legler, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1997. Identification of CCR8, the receptor for the human CC chemokine I-309. J. Biol. Chem. 272:17251-17254. http://dx.doi.org/ 10.1074/jbc.272.28.17251
65. Roozendaal, R., T.R. Mempel, L.A. Pitcher, S.F. Gonzalez, A. Verschoor, R.E. Mebius, U.H. von Andrian, and M.C. Carroll. 2009. Conduits mediate transport of low-molecular-weight antigen to lymph node follicles. Immunity. 30:264-276. http://dx.doi.org/ 10.1016/j.immuni.2008.12.014
66. Roussos, E.T., J.S. Condeelis, and A. Patsialou. 2011. Chemotaxis in cancer. Nat. Rev. Cancer. 11:573-587. http://dx.doi.org/10.1038/nrc3078
67. Ruckes, T., D. Saul, J. Van Snick, O. Hermine, and R. Grassmann. 2001. Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. Blood. 98:1150-1159. http://dx.doi.org/10.1182/blood.V98.4.1150
68. Sainte-Marie, G., F.S. Peng, and C. Bélisle. 1982. Overall architecture and pattern of lymph flow in the rat lymph node. Am. J. Anat. 164:275-309. http://dx.doi.org/10.1002/aja.1001640402
69. Schaerli, P., L. Ebert, K. Willimann, A. Blaser, R.S. Roos, P. Loetscher, and B. Moser. 2004. A skin-selective homing mechanism for human immune surveillance T cells. J. Exp. Med. 199:1265-1275. http://dx.doi.org/10 .1084/jem.20032177
70. Schumann, K., T. Lämmermann, M. Bruckner, D.F. Legler, J. Polleux, J.P. Spatz, G. Schuler, R. Förster, M.B. Lutz, L. Sorokin, and M. Sixt. 2010. Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity. 32:703- 713. http://dx.doi.org/10.1016/j.immuni.2010.04.017
71. Shafie, S.M., and L.A. Liotta. 1980. Formation of metastasis by human breast carcinoma cells (MCF-7) in nude mice. Cancer Lett. 11:81-87. http:// dx.doi.org/10.1016/0304-3835(80)90097-X
72. Shields, J.D., M.S. Emmett, D.B. Dunn, K.D. Joory, L.M. Sage, H. Rigby, P.S. Mortimer, A. Orlando, J.R. Levick, and D.O. Bates. 2007a. Chemokine-mediated migration of melanoma cells towards lymphatics- a mechanism contributing to metastasis. Oncogene. 26:2997-3005. http://dx.doi.org/10.1038/sj.onc.1210114
73. Shields, J.D., M.E. Fleury, C. Yong, A.A. Tomei, G.J. Randolph, and M.A. Swartz. 2007b. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell. 11:526-538. http://dx.doi.org/10.1016/j.ccr .2007.04.020
74. Skobe, M., L.M. Hamberg, T. Hawighorst, M. Schirner, G.L. Wolf, K. Alitalo, and M. Detmar. 2001a. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am. J. Pathol. 159:893-903. http://dx.doi.org/10.1016/S0002-9440(10)61765-8
75. Skobe, M., T. Hawighorst, D.G. Jackson, R. Prevo, L. Janes, P. Velasco, L. Riccardi, K. Alitalo, K. Claffey, and M. Detmar. 2001b. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7:192-198. http://dx.doi.org/10.1038/84643
76. Soler, D., T.R. Chapman, L.R. Poisson, L. Wang, J. Cote-Sierra, M. Ryan, A. McDonald, S. Badola, E. Fedyk, A.J. Coyle, et al. 2006. CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes. J. Immunol. 177:6940-6951.
77. Soule, H.D., T.M. Maloney, S.R. Wolman, W.D. Peterson Jr., R. Brenz, C.M. McGrath, J. Russo, R.J. Pauley, R.F. Jones, and S.C. Brooks. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50:6075-6086.
78. Swartz, M.A. 2001. The physiology of the lymphatic system. Adv. Drug Deliv. Rev. 50:3-20. http://dx.doi.org/10.1016/S0169-409X(01)00150-8
79. Szakal, A.K., K.L. Holmes, and J.G. Tew. 1983. Transport of immune complexes from the subcapsular sinus to lymph node follicles on the surface of nonphagocytic cells, including cells with dendritic morphology. J. Immunol. 131:1714-1727.
80. Tal, O., H.Y. Lim, I. Gurevich, I. Milo, Z. Shipony, L.G. Ng, V. Angeli, and G. Shakhar. 2011. DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling. J. Exp. Med. 208:2141-2153. http://dx.doi.org/10.1084/jem.20102392
81. Tamgüney, G., J. Van Snick, and H. Fickenscher. 2004. Autocrine stimulation of rhadinovirus-transformed T cells by the chemokine CCL1/I-309. Oncogene. 23:8475-8485. http://dx.doi.org/10.1038/sj.onc.1207903
82. Tiffany, H.L., L.L. Lautens, J.L. Gao, J. Pease, M. Locati, C. Combadiere, W. Modi, T.I. Bonner, and P.M. Murphy. 1997. Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309. J. Exp. Med. 186:165-170. http://dx.doi.org/10.1084/jem.186.1.165
83. Tsopelas, C., and R. Sutton. 2002. Why certain dyes are useful for localizing the sentinel lymph node. J. Nucl. Med. 43:1377-1382.
84. van Deurzen, C.H., P.J. Borgstein, and P.J. van Diest. 2008. In-transit lymph node metastases in breast cancer: a possible source of local recurrence after Sentinel Node procedure. J. Clin. Pathol. 61:1314-1316. http://dx.doi .org/10.1136/jcp.2008.059600
85. Van Snick, J., F. Houssiau, P. Proost, J. Van Damme, and J.C. Renauld. 1996. I-309/T cell activation gene-3 chemokine protects murine T cell lymphomas against dexamethasone-induced apoptosis. J. Immunol. 157: 2570-2576.
86. von Andrian, U.H., and T.R. Mempel. 2003. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3:867-878. http://dx.doi.org/10.1038/ nri1222
87. Vona, G., A. Sabile, M. Louha, V. Sitruk, S. Romana, K. Schütze, F. Capron, D. Franco, M. Pazzagli, M. Vekemans, et al. 2000. Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am. J. Pathol. 156:57-63. http://dx.doi.org/10.1016/S0002-9440(10) 64706-2
88. Walen, K.H., and M.R. Stampfer. 1989. Chromosome analyses of human mammary epithelial cells at stages of chemical-induced transformation progression to immortality. Cancer Genet. Cytogenet. 37:249-261. http://dx.doi.org/10.1016/0165-4608(89)90056-3
89. Wiley, H.E., E.B. Gonzalez, W. Maki, M.T. Wu, and S.T. Hwang. 2001. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J. Natl. Cancer Inst. 93:1638-1643. http://dx.doi.org/10.1093/jnci/93.21.1638
90. Wyckoff, J., B. Gligorijevic, D. Entenberg, J. Segall, and J. Condeelis. 2011. High-resolution multiphoton imaging of tumors in vivo. Cold Spring Harb Protoc. 2011:1167-1184.
91. Zakut, R., R. Perlis, S. Eliyahu, Y. Yarden, D. Givol, S.D. Lyman, and R. Halaban. 1993. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells. Oncogene. 8:2221-2229.
92. Zingoni, A., H. Soto, J.A. Hedrick, A. Stoppacciaro, C.T. Storlazzi, F. Sinigaglia, D. D'Ambrosio, A. O'Garra, D. Robinson, M. Rocchi, et al. 1998. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J. Immunol. 161:547-551.